Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine

The p53 tumor suppressor plays a major role in controlling the initiation and development of cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 oncogene is a major negative regulator of p53 that inhibits the activity of p53 and reduces its protein stability. MDM2...

Full description

Bibliographic Details
Main Authors: Jiang-Jiang Qin, Xin Li, Courtney Hunt, Wei Wang, Hui Wang, Ruiwen Zhang
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Genes and Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304218300758
id doaj-0e8e3e5ffc954c60bed5ef426d79541d
record_format Article
spelling doaj-0e8e3e5ffc954c60bed5ef426d79541d2020-11-24T21:24:56ZengElsevierGenes and Diseases2352-30422018-09-0153204219Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicineJiang-Jiang Qin0Xin Li1Courtney Hunt2Wei Wang3Hui Wang4Ruiwen Zhang5Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USADepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USACenter for Drug Discovery, University of Houston, Houston, TX, 77204, USADepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA; Center for Drug Discovery, University of Houston, Houston, TX, 77204, USASchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, ChinaDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA; Center for Drug Discovery, University of Houston, Houston, TX, 77204, USA; Corresponding author. Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4849 Calhoun Road, Houston, TX, 77204, USA. Fax: +1 713 743 1229.The p53 tumor suppressor plays a major role in controlling the initiation and development of cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 oncogene is a major negative regulator of p53 that inhibits the activity of p53 and reduces its protein stability. MDM2, p53, and the p53-MDM2 pathway represent well-documented targets for preventing and/or treating cancer. Natural products, especially those from medicinal and food plants, are a rich source for the discovery and development of novel therapeutic and preventive agents against human cancers. Many natural product-derived MDM2 inhibitors have shown potent efficacy against various human cancers. In contrast to synthetic small-molecule MDM2 inhibitors, the majority of which have been designed to inhibit MDM2-p53 binding and activate p53, many natural product inhibitors directly decrease MDM2 expression and/or MDM2 stability, exerting their anticancer activity in both p53-dependent and p53-independent manners. More recently, several natural products have been reported to target mutant p53 in cancer. Therefore, identification of natural products targeting MDM2, mutant p53, and the p53-MDM2 pathway can provide a promising strategy for the development of novel cancer chemopreventive and chemotherapeutic agents. In this review, we focus our discussion on the recent advances in the discovery and development of anticancer natural products that target the p53-MDM2 pathway, emphasizing several emerging issues, such as the efficacy, mechanism of action, and specificity of these natural products. Keywords: MDM2, Natural products, Oncogene, p53, Tumor suppressorhttp://www.sciencedirect.com/science/article/pii/S2352304218300758
collection DOAJ
language English
format Article
sources DOAJ
author Jiang-Jiang Qin
Xin Li
Courtney Hunt
Wei Wang
Hui Wang
Ruiwen Zhang
spellingShingle Jiang-Jiang Qin
Xin Li
Courtney Hunt
Wei Wang
Hui Wang
Ruiwen Zhang
Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
Genes and Diseases
author_facet Jiang-Jiang Qin
Xin Li
Courtney Hunt
Wei Wang
Hui Wang
Ruiwen Zhang
author_sort Jiang-Jiang Qin
title Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
title_short Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
title_full Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
title_fullStr Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
title_full_unstemmed Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
title_sort natural products targeting the p53-mdm2 pathway and mutant p53: recent advances and implications in cancer medicine
publisher Elsevier
series Genes and Diseases
issn 2352-3042
publishDate 2018-09-01
description The p53 tumor suppressor plays a major role in controlling the initiation and development of cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 oncogene is a major negative regulator of p53 that inhibits the activity of p53 and reduces its protein stability. MDM2, p53, and the p53-MDM2 pathway represent well-documented targets for preventing and/or treating cancer. Natural products, especially those from medicinal and food plants, are a rich source for the discovery and development of novel therapeutic and preventive agents against human cancers. Many natural product-derived MDM2 inhibitors have shown potent efficacy against various human cancers. In contrast to synthetic small-molecule MDM2 inhibitors, the majority of which have been designed to inhibit MDM2-p53 binding and activate p53, many natural product inhibitors directly decrease MDM2 expression and/or MDM2 stability, exerting their anticancer activity in both p53-dependent and p53-independent manners. More recently, several natural products have been reported to target mutant p53 in cancer. Therefore, identification of natural products targeting MDM2, mutant p53, and the p53-MDM2 pathway can provide a promising strategy for the development of novel cancer chemopreventive and chemotherapeutic agents. In this review, we focus our discussion on the recent advances in the discovery and development of anticancer natural products that target the p53-MDM2 pathway, emphasizing several emerging issues, such as the efficacy, mechanism of action, and specificity of these natural products. Keywords: MDM2, Natural products, Oncogene, p53, Tumor suppressor
url http://www.sciencedirect.com/science/article/pii/S2352304218300758
work_keys_str_mv AT jiangjiangqin naturalproductstargetingthep53mdm2pathwayandmutantp53recentadvancesandimplicationsincancermedicine
AT xinli naturalproductstargetingthep53mdm2pathwayandmutantp53recentadvancesandimplicationsincancermedicine
AT courtneyhunt naturalproductstargetingthep53mdm2pathwayandmutantp53recentadvancesandimplicationsincancermedicine
AT weiwang naturalproductstargetingthep53mdm2pathwayandmutantp53recentadvancesandimplicationsincancermedicine
AT huiwang naturalproductstargetingthep53mdm2pathwayandmutantp53recentadvancesandimplicationsincancermedicine
AT ruiwenzhang naturalproductstargetingthep53mdm2pathwayandmutantp53recentadvancesandimplicationsincancermedicine
_version_ 1725985955963207680